With regard to safety concerns, the most prevalent adverse effects associated with GLP-1 RAs are gastrointestinal, such as bloating, dyspepsia, nausea, vomiting, diarrhea and constipation (107)
In a double-blind, placebo-controlled study, overweight participants taking 400mg of Morosil daily the exact dose in Lemme GLP-1 Daily showed significant reductions in body weight, BMI, and waist circumference over 12 weeks
Liraglutide 3.0 mg resulted in an additional 6.2% weight loss from the initial average of 6.0% [42]
Zepbound puede contribuir a un mayor riesgo de tumores de clulas C en la tiroides, pancreatitis aguda, enfermedad de la vescula biliar, hipoglucemia, lesin renal aguda, efectos secundarios gastrointestinales graves, reacciones de hipersensibilidad y empeoramiento de la retinopata diabtica si padece diabetes tipo 2